Myriad Asset Management’s New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a NFH.WS Stock Holding History

Myriad Asset Management’s Portfolio NFH.WS Stock Details NFH.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-169,439	Closed	-$491K	–	158
2021 Q4	$491K	Hold	169,439	–	–	0.05%	102
2021 Q3	$489K	Hold	169,439	–	–	0.05%	118
2021 Q2	$448K	Sell	169,439 -5,061	-3%	-$14.4K	0.03%	116
2021 Q1	$413K	Sell	174,500 -500	-0.3%	-$1.2K	0.04%	106
2020 Q4	$382K	Hold	175,000	–	–	0.08%	60
2020 Q3	$308K	Hold	175,000	–	–	0.07%	45
2020 Q2	$238K	Hold	175,000	–	–	0.04%	43
2020 Q1	$165K	Hold	175,000	–	–	0.02%	86
2019 Q4	$267K	Buy	+175,000	New	+$247K	0.03%	85

Myriad Asset Management's NFH.WS Position: Q1 2022 in Review

Myriad Asset Management sold out of New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a (NFH.WS) in Q1 2022, closing a stake of 169,439 shares — an estimated $491K sold.

Myriad Asset Management first reported a position in NFH.WS in Q4 2019 and held it in 9 quarters. The position peaked at $491K in Q4 2021. 0 funds tracked by Wall St. Rank hold NFH.WS as of Q1 2022.

Myriad Asset Management reported no remaining New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position as of Q1 2022 after selling out during the quarter.
Myriad Asset Management sold 169,439 New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a shares in Q1 2022, an estimated $491K.
Myriad Asset Management first reported a position in New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a in Q4 2019 and held it in 9 quarters.
Myriad Asset Management's New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position peaked at $491K in Q4 2021.
0 funds tracked by Wall St. Rank held New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a as of Q1 2022.

Based on Myriad Asset Management's 13F filing for Q1 2022, filed 16 May 2022.